Compare Novavax Inc (NVAX) vs Opendoor Technologies Inc (OPEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Opendoor Technologies Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Opendoor Technologies Inc trades at $4.48 (market cap $4.29B). The key difference: Opendoor Technologies Inc is far larger — about 3.3× Novavax Inc's market cap. Which is the better fit depends on your goals.
| NVAX | OPEN | |
|---|---|---|
Market Cap | $1.30B | $4.29B |
Sector | Health | Real Estate |
52-Week High | $11.19 | $10.52 |
52-Week Low | $6.22 | $1.84 |
Enterprise Value | $800.50M | $4.63B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →
